logo

For the Inventor, By the Inventor

Durham, NC, United States of America

Oriel Therapeutics, Inc.


USPTO Granted Patents = 39

% Expired Patents = 64.1



Forward Citations = 721

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Thomas W Ruckdeschel (14 out of 14 patents)

silverMedal Anthony James Hickey (12 out of 23 patents)

bronzeMedal Jeffrey Alan Warden (11 out of 18 patents)

4.  Timothy M Crowder (9 out of 12 patents)

5.  David Stuart Harris (9 out of 20 patents)

6.  Andrew Murray Gow (9 out of 10 patents)

7.  Scott Alexander Lewis (9 out of 14 patents)

8.  Jonathan David Tuckwell (8 out of 11 patents)

9.  Michael L King (7 out of 33 patents)

10.  Rachel Striebig (6 out of 15 patents)

11.  Matthew Allen (6 out of 7 patents)

12.  Charles A Buckner, Iii (6 out of 7 patents)

13.  Charles Buckner (6 out of 6 patents)

14.  Andrew J Valentine (5 out of 5 patents)

15.  Cyan Godfrey (4 out of 27 patents)


Core Competencies:
Dry Powder Inhalers
Dosing Heads
Agglomeration Inhibition
Dispensing Methods
Airway Disks
Microcartridges
Blister Packages
Drug Containment Systems
Vibration Feeding
Rotating Piercing Mechanisms
Direct Fill Systems
Fabrication Methods

39 patents:

1. 10493222 - Dry powder dose container assemblies and related inhalers (2019-12-03),
2. 9889953 - Dosing heads for direct fill dry powder systems configured for on/off controlled flow (2018-02-13),
3. 9795749 - Dry powder inhalers with dual piercing members and methods of operating same (2017-10-24),
4. 9597465 - Methods of operating and fabricating inhalers with airway disks having discrete airway channels (2017-03-21),
5. 9339616 - Dry powder inhalers (2016-05-17),
6. 9278767 - Direct fill dry powder systems with dosing heads configured for on/off controlled flow (2016-03-08),
7. D745660 - Dry powder inhaler (2015-12-15),
8. 9050427 - Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods (2015-06-09),
9. 9027551 - Dry powder inhalers that inhibit agglomeration, related devices and methods (2015-05-12),
10. 8991391 - Dry powder inhalers with endless strips and cooperating piercers and related methods (2015-03-31),
11. 8985103 - Dry powder inhalers with dual piercing members (2015-03-24),
12. 8887722 - Inhaler mechanisms with radially biased piercers and related methods (2014-11-18),
13. D711528 - Dry powder inhaler (2014-08-19),
14. D710002 - Inhaler (2014-07-29),
15. 8776840 - Tubular dry powder feeders with axially applied vibration for dry powder filling systems (2014-07-15),
Company Overview
Oriel Therapeutics, Inc. is a biotechnology company based in Durham, North Carolina, focused on developing innovative therapies for respiratory diseases. The company specializes in the formulation and delivery of inhaled medications, leveraging advanced technologies to enhance drug efficacy and patient compliance. Oriel's research emphasizes the optimization of drug delivery systems, aiming to improve treatment outcomes for patients with chronic respiratory conditions. Through its commitment to innovation, Oriel Therapeutics seeks to address unmet medical needs in the respiratory health sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

39 Patents

#28 in Durham, NC

#203 in North Carolina

#8,823 in US

#17,448 in the World

Durham, NC (US)
Durham, NC, United States of America

Oriel Therapeutics, Inc.

Forward Citations = 721

42 inventors:

goldMedal Thomas W Ruckdeschel (14 out of 14 patents)

silverMedal Anthony James Hickey (12 out of 23 patents)

bronzeMedal Jeffrey Alan Warden (11 out of 18 patents)

4.  Timothy M Crowder (9 out of 12 patents)

5.  David Stuart Harris (9 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Oriel Therapeutics, Inc.. Retrieved from https://idiyas.com/company/oriel-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…